Efficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty
NCT06926933
·
clinicaltrials.gov ↗
PHASE4
Phase
RECRUITING
Status
50
Enrollment
INDUSTRY
Sponsor class
Conditions
CPP
Interventions
DRUG:
Eligard® 45 mg
Sponsor
HanAll BioPharma Co., Ltd.